RecruitingPhase 2NCT06226883A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's DiseaseSponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)Cedar Park, TX · Denton, TX · Houston, TX · +22 more sites
RecruitingPhase 2NCT06548542Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's DiseaseSponsor: AbbVieCedar Park, TX · El Paso, TX · Garland, TX · +61 more sites
RecruitingPhase 4NCT06045754A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's DiseaseSponsor: TakedaCedar Park, TX · Dallas, TX · Houston, TX · +38 more sites
RecruitingPhase 2NCT06456593Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's DiseaseSponsor: Abivax S.A.Austin, TX · Baytown, TX · Bellaire, TX · +40 more sites